Bei B. Zhang

Bei B. Zhang currently serves as the Corporate Vice President at Novo Nordisk, a position held since August 2023. Prior to this role, Zhang has accumulated extensive experience at Pfizer as Vice President since May 2017 and at Eli Lilly and Company, where roles included Vice President of Research and General Manager of the Lilly China Research and Development Center from August 2010 to May 2017. At Merck, Zhang held several significant positions, including Franchise Site Lead for Diabetes and Senior Director for Metabolic Disorders from August 2001 to August 2010. Educational qualifications include a Ph.D. from Indiana University School of Medicine, a Postdoctoral Fellowship from Stanford University, and a program at Harvard Business School in 2014.